5-Fluorouracil CAS NO (51-21-8) Powder available for sale

Introduction to 5-Fluorouracil (51-21-8): A Potent Anticancer Agent 5-Fluorouracil (5-FU) emerges as a potent chemotherapeutic agent, renowned for its efficacy in treating various solid tumors, including colorectal, breast, and gastrointestinal cancers, marking a significant milestone in cancer therapy.

Chemical Structure of 5-Fluorouracil (51-21-8): Unraveling the Modified Nucleobase Explore the chemical structure of 5-Fluorouracil, a fluorinated analogue of the nucleobase uracil, and decipher how this modification enhances its cytotoxicity by disrupting nucleic acid synthesis in cancer cells.

Synthesis Pathways of 5-Fluorouracil (51-21-8): From Fluorine Substitution to Therapeutic Application Trace the synthetic routes to 5-Fluorouracil, encompassing fluorination methodologies and organic synthesis strategies, illustrating its transformation from laboratory discovery to clinical use as a cornerstone in cancer treatment.

Mechanism of Action of 5-Fluorouracil (51-21-8): Targeting DNA and RNA Synthesis Investigate the mechanism of action of 5-Fluorouracil, where it exerts its antineoplastic effects by inhibiting thymidylate synthase, disrupting DNA replication, and incorporating into RNA, leading to cytotoxicity in cancer cells.

Clinical Applications of 5-Fluorouracil (51-21-8) in Cancer Therapy Explore the diverse clinical applications of 5-Fluorouracil across various malignancies, including colorectal, breast, and pancreatic cancers, as a monotherapy or in combination with other chemotherapeutic agents, showcasing its versatility in oncology.

1. Introduction to Fluorouracil (5-FU, 51-21-8): Fluorouracil, commonly abbreviated as 5-FU, is a chemotherapeutic agent used in the treatment of various cancers, including colorectal, breast, and skin cancers. It belongs to the class of fluoropyrimidines and is one of the most widely used anticancer drugs.

2. Chemical Composition and Structure: Fluorouracil is a fluorinated analog of the naturally occurring pyrimidine uracil. Its structure contains a fluorine atom substituted at the 5-position of the pyrimidine ring.

3. Mechanism of Action: Fluorouracil interferes with DNA and RNA synthesis by inhibiting the enzyme thymidylate synthase, leading to the depletion of thymidine nucleotides essential for DNA replication. This ultimately results in inhibition of cell growth and induction of apoptosis in cancer cells.

4. Pharmacokinetics: Following administration via various routes (e.g., intravenous, topical), fluorouracil is metabolized primarily in the liver and rapidly cleared from the body. Its metabolites are excreted mainly through urine.

5. Clinical Indications: Fluorouracil is indicated for the treatment of various solid tumors, including colorectal cancer, breast cancer, gastrointestinal cancers, and skin cancers such as basal cell carcinoma and squamous cell carcinoma.

6. Dosing and Administration: The dosing and administration of fluorouracil depend on factors such as the type and stage of cancer, patient's overall health, and treatment regimen (e.g., monotherapy or combination therapy). It can be administered intravenously, topically, or via other routes depending on the indication.